Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1061128914 | 10611289 | 14 | F | 20140602 | 20160818 | 20141126 | 20160824 | EXP | PHHY2013CA109298 | NOVARTIS | 53.05 | YR | F | Y | 0.00000 | 20160824 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1061128914 | 10611289 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | Y | 21588 | 400 | MG | TABLET | QD | |||||
| 1061128914 | 10611289 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 200 MG, QD | Y | 21588 | 200 | MG | TABLET | QD | |||||
| 1061128914 | 10611289 | 3 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 100 MG, BID | Y | 21588 | 100 | MG | TABLET | BID | |||||
| 1061128914 | 10611289 | 4 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 1061128914 | 10611289 | 5 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | Unknown | U | 0 | ||||||||||
| 1061128914 | 10611289 | 6 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | U | 0 | |||||||||||
| 1061128914 | 10611289 | 7 | C | APO PROCHLORPERAZINE | 2 | Unknown | U | 0 | |||||||||||
| 1061128914 | 10611289 | 8 | C | BETAHISTINE | BETAHISTINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1061128914 | 10611289 | 1 | Gastrointestinal stromal tumour |
| 1061128914 | 10611289 | 4 | Product used for unknown indication |
| 1061128914 | 10611289 | 5 | Myalgia |
| 1061128914 | 10611289 | 6 | Speech disorder |
| 1061128914 | 10611289 | 7 | Product used for unknown indication |
| 1061128914 | 10611289 | 8 | Dizziness |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1061128914 | 10611289 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1061128914 | 10611289 | Abdominal distension | |
| 1061128914 | 10611289 | Abdominal pain | |
| 1061128914 | 10611289 | Abdominal pain upper | |
| 1061128914 | 10611289 | Alopecia | |
| 1061128914 | 10611289 | Arthralgia | |
| 1061128914 | 10611289 | Arthritis | |
| 1061128914 | 10611289 | Asthenia | |
| 1061128914 | 10611289 | Back pain | |
| 1061128914 | 10611289 | Benign neoplasm of thyroid gland | |
| 1061128914 | 10611289 | Blood cholesterol increased | |
| 1061128914 | 10611289 | Blood iron decreased | |
| 1061128914 | 10611289 | Chest pain | |
| 1061128914 | 10611289 | Chills | |
| 1061128914 | 10611289 | Cognitive disorder | |
| 1061128914 | 10611289 | Confusional state | |
| 1061128914 | 10611289 | Constipation | |
| 1061128914 | 10611289 | Contusion | |
| 1061128914 | 10611289 | Cough | |
| 1061128914 | 10611289 | Dehydration | |
| 1061128914 | 10611289 | Diarrhoea | |
| 1061128914 | 10611289 | Dizziness | |
| 1061128914 | 10611289 | Dry eye | |
| 1061128914 | 10611289 | Dyspepsia | |
| 1061128914 | 10611289 | Dysphagia | |
| 1061128914 | 10611289 | Dyspnoea | |
| 1061128914 | 10611289 | Eye haemorrhage | |
| 1061128914 | 10611289 | Eye pruritus | |
| 1061128914 | 10611289 | Fatigue | |
| 1061128914 | 10611289 | Feeling abnormal | |
| 1061128914 | 10611289 | Flatulence | |
| 1061128914 | 10611289 | Gastrointestinal motility disorder | |
| 1061128914 | 10611289 | Gastrointestinal pain | |
| 1061128914 | 10611289 | Gastrooesophageal reflux disease | |
| 1061128914 | 10611289 | Haemoglobin decreased | |
| 1061128914 | 10611289 | Headache | |
| 1061128914 | 10611289 | Hypersensitivity | |
| 1061128914 | 10611289 | Hypersomnia | |
| 1061128914 | 10611289 | Incision site erythema | |
| 1061128914 | 10611289 | Incision site pain | |
| 1061128914 | 10611289 | Incision site swelling | |
| 1061128914 | 10611289 | Keloid scar | |
| 1061128914 | 10611289 | Malaise | |
| 1061128914 | 10611289 | Memory impairment | |
| 1061128914 | 10611289 | Micturition urgency | |
| 1061128914 | 10611289 | Muscle spasms | |
| 1061128914 | 10611289 | Nasal pruritus | |
| 1061128914 | 10611289 | Nausea | |
| 1061128914 | 10611289 | Odynophagia | |
| 1061128914 | 10611289 | Oesophageal discomfort | |
| 1061128914 | 10611289 | Oropharyngeal pain | |
| 1061128914 | 10611289 | Pain | |
| 1061128914 | 10611289 | Pollakiuria | |
| 1061128914 | 10611289 | Poor quality sleep | |
| 1061128914 | 10611289 | Pruritus | |
| 1061128914 | 10611289 | Pyrexia | |
| 1061128914 | 10611289 | Rhinorrhoea | |
| 1061128914 | 10611289 | Secretion discharge | |
| 1061128914 | 10611289 | Somnolence | |
| 1061128914 | 10611289 | Speech disorder | |
| 1061128914 | 10611289 | Sputum discoloured | |
| 1061128914 | 10611289 | Swelling face | |
| 1061128914 | 10611289 | Underdose | |
| 1061128914 | 10611289 | Vomiting | |
| 1061128914 | 10611289 | Weight increased | |
| 1061128914 | 10611289 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1061128914 | 10611289 | 1 | 20130926 | 201501 | 0 |